IRIDEX Corporation provided revenue guidance for the year 2023. With lower-than-expected probe unit sales growth and capital equipment softness in the first half of the year, the Company is updating its full year 2023 expectations as follows: Cyclo G6 probe sales of 61,000 to 63,000 units representing approximately 1% to 5% growth over 2022 and Cyclo G6 systems installed base expansion of 210 to 230 systems. Total revenue for the full year is expected to be $55 million to $57 million, representing flat to 3% growth year-over-year, after adjusting for approximately $1.5 million reduction in royalty revenue. The updated financial outlook reflects stabilization in capital equipment demand and a more gradual G6 probe utilization ramp.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.65 USD | 0.00% | -8.07% | -6.76% |
14/05 | Transcript : IRIDEX Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | Earnings Flash (IRIX) IRIDEX CORPORATION Posts Q1 Revenue $11.8M, vs. Street Est of $12M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.76% | 4.31Cr | |
+12.56% | 23TCr | |
+13.99% | 20TCr | |
+18.28% | 14TCr | |
+28.43% | 11TCr | |
+3.27% | 6.49TCr | |
+18.42% | 5.43TCr | |
+7.04% | 5.21TCr | |
+11.19% | 4.52TCr | |
+5.21% | 3.74TCr |
- Stock Market
- Equities
- IRIX Stock
- News IRIDEX Corporation
- IRIDEX Corporation Provides Revenue Guidance for the Year 2023